These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8534260)

  • 1. Transmural regulation of myocardial perfusion by neuropeptide Y.
    Gutterman DD; Morgan DA
    Basic Res Cardiol; 1995; 90(4):348-55. PubMed ID: 8534260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y modulates vasoconstriction in coronary microvessels in the beating canine heart.
    Komaru T; Ashikawa K; Kanatsuka H; Sekiguchi N; Suzuki T; Takishima T
    Circ Res; 1990 Nov; 67(5):1142-51. PubMed ID: 2225353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
    Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A
    Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
    Awad SJ; Einstein R; Potter EK; Richardson DP
    Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
    Tanaka E; Mori H; Chujo M; Yamakawa A; Mohammed MU; Shinozaki Y; Tobita K; Sekka T; Ito K; Nakazawa H
    J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs.
    Otani N; Yang T; Levy MN
    Circ Res; 1993 Apr; 72(4):816-26. PubMed ID: 8443869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.
    Maturi MF; Greene R; Speir E; Burrus C; Dorsey LM; Markle DR; Maxwell M; Schmidt W; Goldstein SR; Patterson RE
    J Clin Invest; 1989 Apr; 83(4):1217-24. PubMed ID: 2703530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery.
    Aizawa Y; Murata M; Hayashi M; Funazaki T; Ito S; Shibata A
    Jpn Circ J; 1985 Jun; 49(6):584-8. PubMed ID: 3839860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neuropeptide Y on regulation of blood flow rate in canine myocardium.
    Svendsen JH; Sheikh SP; Jørgensen J; Mikkelsen JD; Paaske WP; Sejrsen P; Haunsø S
    Am J Physiol; 1990 Dec; 259(6 Pt 2):H1709-17. PubMed ID: 2260698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
    Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
    Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of the vasoconstrictor action of neuropeptide-Y by calcium-channel blockers.
    Aizawa Y; Niwano S; Aizawa M; Tamura M; Shibata A
    Angiology; 1989 Oct; 40(10):890-4. PubMed ID: 2802259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmural redistribution of myocardial blood flow during isoflurane anesthesia and its effects on regional myocardial function in a canine model of fixed coronary stenosis.
    Wilton NC; Knight PR; Ullrich K; Martin B; Gallagher KP
    Anesthesiology; 1993 Mar; 78(3):510-23. PubMed ID: 8457052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.
    Pernow J; Kahan T; Lundberg JM
    Br J Pharmacol; 1988 Jul; 94(3):952-60. PubMed ID: 3179619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of intracoronary neuropeptide Y in dogs: resistance to alpha adrenergic blockade.
    Stack RK; Patterson RE
    Cardiovasc Res; 1991 Sep; 25(9):757-63. PubMed ID: 1666019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nifedipine on neuropeptide Y-induced coronary vasoconstriction in anesthetized dogs.
    Hayashi M; Aizawa Y; Satoh M; Suzuki K; Shibata A
    Jpn Heart J; 1986 Mar; 27(2):251-7. PubMed ID: 3755186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional myocardial blood flow in awake dogs.
    Cobb FR; Bache RJ; Greenfield JC
    J Clin Invest; 1974 Jun; 53(6):1618-25. PubMed ID: 4830226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of adrenergic coronary vasoconstriction via ATP-sensitive potassium channel.
    Mori H; Chujo M; Tanaka E; Yamakawa A; Shinozaki Y; Mohamed MU; Nakazawa H
    Am J Physiol; 1995 Mar; 268(3 Pt 2):H1077-85. PubMed ID: 7900861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol on regional myocardial blood flow and oxygen consumption.
    Warltier DC; Gross GJ; Hardman HF
    J Pharmacol Exp Ther; 1976 Aug; 198(2):435-43. PubMed ID: 948034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.